Enforcing patent rights may be as expensive as getting products cleared through the FDA in a couple of years.
I do think that your primary point about the company's needing to communicate more and better with the investor community is spot-on. The Investor Relations consultant, Paul Knopick, has in my opinion done a fine job here for a couple of years, and I do think that more openness on the financial and personnel picture (e.g. what's going on with debt conversions, why did Moreno and presumptively Perlingos leave, what were sales in April and May since they told us what sales in June were, etc.) would be beneficial to both the company and its investors.
I realize that there is a thin line between press release material and SEC filing material, and that there's a need for greater legal and substantive precision in SEC filings - but I do believe that companies which can be trusted to keep their shareholders updated are rewarded with higher price-earnings ratios in their stock (and this company may very well be on the verge of actually having positive earnings).
It would be interesting if the sell-side on all the high volume of recent weeks has been more attributable to Perlingos (and Moreno as well, perhaps) selling shares rather than debt-conversion newly-issued shares being dumped by Iliad/Typenex/Fife. I also wouldn't rule out - though you might think it to be a real stretch - that Perlingos resigned so that he could put together an offer to buy the company.
We'll see soon enough, I guess. Thanks again for our interactions this morning.
